Insulet Corporation
PODD·NASDAQ NMS - GLOBAL MARKET
Compare PeersSnapshot
Valuation
Market Cap
P/E (TTM)
P/Sales
EV/EBITDA
P/Book
Cash Flow
Operating CF$619.30M
Free Cash Flow$415.70M
FCF Yield
Margins & Growth
Gross Margin71.01%
Oper. Margin17.48%
Net Margin10.44%
Balance Sheet
Cash$480.40M
Total Assets$2.99B
Total Debt$929.50M
Dividends
Div Yield
DPS (TTM)N/A
Net Debt$449.10M
Company Profile
CEO
Ms. Ashley A. McEvoy
Website
Sector
Health Care
Industry
Health Care Equipment
Full Time Employees
-
Country
US
Exchange
NASDAQ NMS - GLOBAL MARKET
A Insulet Corporation é uma empresa focada em desenvolver soluções inovadoras para diabéticos através de sistemas de bombagem de insulina. Os rendimentos provêm principalmente da venda contínua destas unidades a pacientes.
